These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 5668294)

  • 21. [Pyrazinamide, cycloserine and ethionamide in the complex treatment of pulmonary tuberculosis].
    Aspevik E
    Tidsskr Nor Laegeforen; 1967 Mar; 87(6):548-54. PubMed ID: 6047184
    [No Abstract]   [Full Text] [Related]  

  • 22. [An experimental intermittent method of treating tuberculosis].
    Shlapak PT; Belinskiĭ AN
    Probl Tuberk; 1971; 49(12):75-7. PubMed ID: 5159695
    [No Abstract]   [Full Text] [Related]  

  • 23. [Overview on preclinical research on tuberculosis chemotherapy in the past 100 years. (2) Experimental studies following clinical tests].
    Kanei T; Kondo E
    Kekkaku; 1983 Apr; 58(4):235-45. PubMed ID: 6632485
    [No Abstract]   [Full Text] [Related]  

  • 24. [Experimental therapy with so-called "minor" tuberculostatics].
    Freerksen E
    Wien Med Wochenschr; 1966 Oct; 116(42):874-7. PubMed ID: 6005730
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of administration of more tuberculostatics on experimental tuberculosis].
    Durisić M; Drndarski K; Leposavić V
    Glas Srp Akad Nauka Med; 1969; (22):125-36. PubMed ID: 5202709
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of sodium nucleinate on the development of morphologic reactions during antibacterial therapy of experimental tuberculosis].
    Baranova TV
    Probl Tuberk; 1986; (12):46-50. PubMed ID: 3823082
    [No Abstract]   [Full Text] [Related]  

  • 27. Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus.
    Kam KM; Yip CW
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):760-6. PubMed ID: 15182147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Relations between the indices of cellular immunity during chemotherapy of experimental tuberculosis].
    Gavrilenko AF; Stasiuk IM; Sibirnaia RI; Beliakova OI
    Probl Tuberk; 1983 Sep; (9):61-3. PubMed ID: 6647448
    [No Abstract]   [Full Text] [Related]  

  • 29. Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis.
    Pandey R; Khuller GK
    Tuberculosis (Edinb); 2005 Jul; 85(4):227-34. PubMed ID: 15922668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Dynamics of the rosette formation indices in the experimental tuberculosis chemotherapy process].
    Sibirnaia RI
    Probl Tuberk; 1981 Jun; (6):54-7. PubMed ID: 7279911
    [No Abstract]   [Full Text] [Related]  

  • 31. [EXPERIMENTAL AND CLINICAL OBSERVATIONS ON THE ANTITUBERCULAR ACTIVITY OF ETHIONAMIDE].
    GRASSI C; CLINI V; RIMOLDI R
    G Ital Chemioter; 1963; 10():146-50. PubMed ID: 14074252
    [No Abstract]   [Full Text] [Related]  

  • 32. Hemagglutination phenomenon between tanned erythrocytes and serum of guinea pigs. Effect of chemotherapeutic treatment on tanned erythrocyte-agglutinating activity of serum in experimental tuberculosis of guinea pigs.
    Ito R; Sassa K; Akiyama M
    Jpn J Tuberc; 1965 Jul; 13(1):9-15. PubMed ID: 5295220
    [No Abstract]   [Full Text] [Related]  

  • 33. [Urgent problems of antibacterial treatment of pulmonary tuberculosis].
    Pilipchuk NS
    Vrach Delo; 1981 Jan; (1):47-9. PubMed ID: 7010782
    [No Abstract]   [Full Text] [Related]  

  • 34. Lectin-functionalized poly (lactide-co-glycolide) nanoparticles as oral/aerosolized antitubercular drug carriers for treatment of tuberculosis.
    Sharma A; Sharma S; Khuller GK
    J Antimicrob Chemother; 2004 Oct; 54(4):761-6. PubMed ID: 15329364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Resistance to ethambutol and capreomycine in experimental tuberculosis in guinea pigs].
    Janowiec M
    Gruzlica; 1969 Jul; 37(7):645-8. PubMed ID: 5350927
    [No Abstract]   [Full Text] [Related]  

  • 36. Nanotechnology based drug delivery system(s) for the management of tuberculosis.
    Pandey R; Khuller GK
    Indian J Exp Biol; 2006 May; 44(5):357-66. PubMed ID: 16708887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Influence of treatment by ethionamide on the morphologic dynamics of experimental tuberculous inflammation].
    Diaconita G; Eskenasy A; Stoica E
    Poumon Coeur; 1965; 21(9):1115-24. PubMed ID: 5845716
    [No Abstract]   [Full Text] [Related]  

  • 38. [Pathomorphology of tuberculosis after the treatment with antibacterial drugs and amniocene].
    Sapozhnik KG; Khaĭdarly IN; Ustiian AI
    Probl Tuberk; 1990; (12):60-2. PubMed ID: 2084699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Correction of immunologic deficiency in experimental tuberculosis and chronic effect of pesticides].
    Arifkhanova SI; Vakhidova GA
    Probl Tuberk; 1991; (5):61-4. PubMed ID: 1924247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment modalities applied to tuberculosis patients in a French department. Hautes-Pyrénées, 1973 to 1980].
    Hetrick G; Humarau H
    Rev Fr Mal Respir; 1983; 11(6):883-7. PubMed ID: 6669799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.